CBPD-409 is an orally active PROTAC degrader for CBP/p300, with DC50 of 0.2-0.4 nM. CBPD-409 exhibits antiproliferative effects in AR+ prostate cancer cell lines VCaP, LNCaP and 22Rv1, with IC50s of 1.2-2.0 nM. CBPD-409 exhibits antitumor efficacy (Red: CBP inhibitor GNE049 (HY-108435), Blue: CRBN/cullin 4A Thalidomide (HY-14658), Black: Linker)[1].
Molecular Weight:
862.97
Purity:
99.38
CAS Number:
[3037549-86-0]
Formula:
C46H52F2N10O5
Target:
Histone Acetyltransferase,PROTACs
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted